Neurocrine Biosciences
NBIX
#1461
Rank
S$15.95 B
Marketcap
$160.02
Share price
1.03%
Change (1 day)
-11.71%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): S$0.68 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are S$2.35 Billion. , an increase over its 2023 earnings that were of S$0.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 S$0.69 B64.57%
2023 S$0.42 B41.13%
2022 S$0.29 B73.74%
2021 S$0.17 B-8.82%
2020 S$0.18 B77.78%
2019 S$0.10 B49.83%
2018 S$70.59 M-142.57%
2017 -S$0.17 Billion-14.73%
2016 -S$0.2 Billion53.15%
2015 -S$0.13 Billion46.25%
2014 -S$86.82 Million29.66%
2013 -S$66.97 Million-3530.8%
2012 S$1.95 M-95.73%
2011 S$45.72 M
2009 -S$64.28 Million-45.38%
2008 -S$0.12 Billion-58.87%
2007 -S$0.29 Billion87.3%
2006 -S$0.16 Billion351.97%
2005 -S$33.8 Million-52.09%
2004 -S$70.55 Million-10.98%
2003 -S$79.24 Million
2001 -S$59.15 Million
1999 -S$26.68 Million108.32%
1998 -S$12.81 Million
1996 S$3.9 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$25.91 M-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
S$2.09 B 203.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
-S$36.31 Million-105.25%๐Ÿ‡บ๐Ÿ‡ธ USA
S$17.09 B 2,370.37%๐Ÿ‡บ๐Ÿ‡ธ USA
S$5.00 B 623.94%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.35 B 1,252.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$10.12 Million-101.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$56.3 Million-108.14%๐Ÿ‡บ๐Ÿ‡ธ USA